Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Progenics Pharmaceuticals Inc (PGNX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Ardsley Partners

Philip Hempleman

2,130,000 $17,125 2.57%
2. 2,536,000 $20,389 +6% 1.33%
3.
Ardsley PartnersCALL

Philip Hempleman

250,000 $2,010 0.3%
4.
Opus Point Partners Management

Michael S. Weiss And Lindsay A. Rosenwald

10,891 $88 0.19%
5.
Farallon Capital

Thomas Steyer

2,651,100 $21,315 0.13%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.90 5,000 Director 909,891 2010-12-01 Filing
$4.73 388,659 Large Shareholder 8,951,169 2014-07-21 Filing
$4.73 388,200 Large Shareholder 8,562,510 2014-07-18 Filing
$4.48 436,884 Large Shareholder 8,174,310 2014-07-17 Filing
$4.48 411,693 Large Shareholder 7,737,426 2014-07-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.55 150,000 Large Shareholder 6,997,269 2017-02-15 Filing
$9.68 150,000 Large Shareholder 7,147,269 2017-02-14 Filing
$9.70 100,000 Large Shareholder 7,297,269 2017-02-14 Filing
$9.70 50,000 Large Shareholder 7,397,269 2017-02-14 Filing
$9.70 52,600 Large Shareholder 7,447,269 2017-02-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,762,978 $14,174 1.21%
2. 90,177 $725 0.64%
3. 1,389,840 $11,174 0.4%
4. 125,115 $1,006 0.35%
5. 1,789,073 $14,384 0.29%
News See All